Profiling of vitreous proteomes from proliferative diabetic retinopathy and nondiabetic patients

Proteomics

Volumn 7, Issue 22, 2007, Pages 4203-4215

  Kim, Taeoh ^a   Sang, Jin Kim ^a   Kim, Kyunggon ^a   Kang, Un Beom ^b   Lee, Cheolju ^b   Kyong, Soo Park ^a   Hyeong, Gon Yu ^a   Kim, Youngsoo ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Korea Institute of Science and Technology   (South Korea)

Author keywords

Clinical proteomics; Diabetes; Diabetic retinopathy; Vitreous humor

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC RETINOPATHY; ELECTROSPRAY MASS SPECTROMETRY; HUMAN; HUMAN TISSUE; LIQUID CHROMATOGRAPHY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; TANDEM MASS SPECTROMETRY; VITREOUS BODY;

ADULT; AGED; CHROMATOGRAPHY, LIQUID; DIABETIC RETINOPATHY; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EYE PROTEINS; HUMANS; MIDDLE AGED; PROTEOMICS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TANDEM MASS SPECTROMETRY; VITREOUS BODY;

EID: 36549073658     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.200700745     Document Type: Article

References (61)

1. CDC, National Diabetes Fact Sheet: General information and National Estimates on Diabetes in the United States, US Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta, GA 2005.
2. Klein, R., Klein, B. E., Moss, S. E., Cruickshanks, K. J., The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. Ophthalmology 1998, 105, 1801-1815.
3. Schroder, S., Palinski, W., Schmid-Schonbein, G. W., Activated monocytes and granulocytes, capillary nonperfusion, and neovascularization in diabetic retinopathy. Am. J. Pathol. 1991, 139, 81-100.
4. Krogsaa, B., Lund-Andersen, H., Mehlsen, J., Sestoft, L., Larsen, J., The blood-retinal barrier permeability in diabetic patients. Acta Ophthalmol. 1981, 59, 689-694.
5. Bursell, S. E., Clermont, A. C., Kinsley, B. T., Simonson, D. C., et al., Retinal blood flow changes in patients with insulin-dependent diabetes mellitus and no diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 1996, 37, 886-897.
6. Gardner, T. W., Antonetti, D. A., Barber, A. J., LaNoue, K. F., Levison, S. W., Diabetic retinopathy: More than meets the eye. Surv. Ophthalmol. 2002, 47, S253-S262.
7. Ferris, F. L., Davis, M., Early Treatment Diabetic Retinopathy Study Research Group. Early Treatment Diabetic Retinopathy Study Research Group No. 1: Photocoagulation for diabetic macular edema. Early treatment diabetic retinopathy study report no. 1: Photocoagulation for diabetic macular edema. Arch. Ophthalmol. 1985, 103, 1796-1806.
8. Lewis, H., Abrams, G. W., Blumenkranz, M. S., Campo, R. V., Vitrectomy for diabetic macular traction and edema associated with posterior hyaloidal traction. Ophthalmology 1992, 99, 753-759.
9. Witmer, A. N., Blaauwgeers, H. G., Weich, H. A., Alitalo, K., et al., Altered expression patterns of VEGF receptors in human diabetic retina and in experimental VEGF-induced retinopathy in monkey. Invest. Ophthalmol. Vis. Sci. 2002, 43, 849-857.
10. Pe'er, J., Folberg, R., Itin, A., Gnessin, H., et al., Upregulated expression of vascular endothelial growth factor in proliferative diabetic retinopathy. Br. J. Ophthalmol. 1996, 80, 241-245.
11. Mathews, M. K., Merges, C., McLeod, D. S., Lutty, G. A., Vascular endothelial growth factor and vascular permeability changes in human diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 1997, 38, 2729-2741.
12. Witmer, A. N., Vrensen, G. F., Van Noorden, C. J., Schlingemann, R. O., Vascular endothelial growth factors and angiogenesis in eye disease. Prog. Retin. Eye Res. 2003, 22, 1-29.
13. Kida, T., Ikeda, T., Nishimura, M., Sugiyama, T., et al., Renin-angiotensin system in proliferative diabetic retinopathy and its gene expression in cultured human muller cells. Jpn. J. Ophthalmol. 2003, 47, 36-41.
14. Guidry, C., Feist, R., Morris, R., Hardwick, C. W., Changes in IGF activities in human diabetic vitreous. Diabetes 2004, 53, 2428-2435.
15. Ohashi, H., Takagi, H., Koyama, S., Oh, H., et al., Alterations in expression of angiopoietins and the Tie-2 receptor in the retina of streptozotocin induced diabetic rats. Mol. Vis. 2004, 10, 608-617.
16. Watanabe, D., K., S., Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy. New Eng. J. Med. 2005, 353, 782-792.
17. Mitamura, Y., Tashimo, A., Nakamura, Y., Tagawa, H., et al., Vitreous levels of placenta growth factor and vascular endothelial growth factor in patients with proliferative diabetic retinopathy. Diabetes Care 2002, 25, 2352.
18. Matsumoto, Y., Takahashi, M., Chikuda, M., Arai, K., Levels of mature cross-links and advanced glycation end product cross-links in human vitreous. Jpn. J. Ophthalmol. 2002, 46, 510-517.
19. Dawson, D. W., Volpert, O. V., Gillis, P., Crawford, S. E., et al., Pigment epithelium-derived factor: A potent inhibitor of angiogenesis. Science 1999, 285, 245-248.
20. Duh, E. J., Yang, H. S., Suzuma, I., Miyagi, M., et al., Pigment epithelium-derived factor suppresses ischemia-induced retinal neovascularization and VEGF-induced migration and growth. Invest. Ophthalmol. Vis. Sci. 2002, 43, 821-829.
21. Spranger, J., Osterhoff, M., Reimann, M., Mohlig, M., et al., Loss of the antiangiogenic pigment epithelium-derived factor in patients with angiogenic eye disease. Diabetes 2001, 50, 2641-2645.
22. Nakanishi, T., Koyama, R., Ikeda, T., Shimizu, A., Catalogue of soluble proteins in the human vitreous humor: Comparison between diabetic retinopathy and macular hole. J. Chromatogr. 2002, 776, 89-100.
23. Ouchi, M., West, K., Crabb, J. W., Kinoshita, S., Kamei, M., Proteomic analysis of vitreous from diabetic macular edema. Exp. Eye Res. 2005, 81, 176-182.
24. Yamane, K., Minamoto, A., Yamashita, H., Takamura, H., et al., Proteome analysis of human vitreous proteins. Mol. Cell Proteomics 2003, 2, 1177-1187.
25. Kim, S. J., Kim, S., Park, J., Lee, H. K., et al., Differential expression of vitreous proteins in proliferative diabetic retinopathy. Curr. Eye Res. 2006, 31, 231-240.
26. Nesvizhskii, A. I., Aebersold, R., Interpretation of shotgun proteomic data: The protein inference problem. Mol. Cell. Proteomics 2005, 4, 1419-1440.
27. Nesvizhskii, A. I., Keller, A., Kolker, E., Aebersold, R., A statistical model for identifying proteins by tandem mass spectrometry. Anal. Chem. 2003, 75, 4646-4658.
28. Johnson, M. W., Improvements in the understanding and treatment of macular hole. Curr. Opin. Ophthalmol. 2002, 13, 152-160.
29. Shevchenko, A., Wilm, M., Vorm, O., Mann, M., Mass spectrometric sequencing of proteins silver-stained Polyacrylamide gels. Anal. Chem. 1996, 68, 850-858.
30. Boeckmann, B., Bairoch, A., Apweiler, R., Blatter, M. C., et al., The SWISS-PROT protein knowledgebase and its supplement TrEMBL in 2003. Nucleic Acids Res. 2003, 31, 365-370.
31. Camon, E., Magrane, M., Barrell, D., Lee, V., et al., The Gene Ontology Annotation (GOA) Database: Sharing knowledge in Uniprot with Gene Ontology. Nucleic Acids Res. 2004, 32, D262-D266.
32. Huang, L., Harvie, G., Feitelson, J. S., Gramatikoff, K., et al., Immunoaffinity separation of plasma proteins by IgY microbeads: Meeting the needs of proteomic sample preparation and analysis. Proteomics 2005, 5, 3314-3328.
33. Liu, T., Qian, W. J., Mottaz, H. M., Gritsenko, M. A., et al., Evaluation of multiprotein immunoaffinity subtraction for plasma proteomics and candidate biomarker discovery using mass spectrometry. Mol. Cell. Proteomics 2006, 5, 2167-2174.
34. Cho, C. K., Shan, S. J., Winsor, E. J., Diamandis, E. P., Proteomic analysis of human amniotic fluid. Mol. Cell. Proteomics 2007 6, 1406-1415.
35. Koyama, R., Nakanishi, T., Ikeda, T., Shimizu, A., Catalogue of soluble proteins in human vitreous humor by one-dimensional sodium dodecyl sulfate-polyacrylamide gel electrophoresis and electrospray ionization mass spectrometry including seven angiogenesis-regulating factors. J. Chromatogr. 2003, 792, 5-21.
36. Wu, C., W., Sauter, J. L., Johnson, P. K., Chen, C. D., Olsen, T. W., Identification and localization of major soluble vitreous proteins in human ocular tissue. Am. J. Ophthalmol. 2004, 137, 655-661.
37. Gao, B. B., Clermont, A., Rook, S., Fonda, S. J., et al., Extracellular carbonic anhydrase mediates hemorrhagic retinal and cerebral vascular permeability through prekallikrein activation. Nat. Med. 2007, 13, 181-188.
38. Meyer-Schwickerath, R., Pfeiffer, A., Blum, W. F., Freyberger, H., et al., Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye disease. Studies in nondiabetic and diabetic subjects. J. Clin. Invest. 1993, 92, 2620-2625.
39. Lofqvist, C., Chen, J., Connor, K. M., Smith, A. C., et al., From the Cover: IGFBP3 suppresses retinopathy through suppression of oxygen-induced vessel loss and promotion of vascular regrowth. Proc. Natl. Acad. Sci. USA 2007, 104, 10589-10594.
40. Miyazawa, K., Shimomura, T., Kitamura, A., Kondo, J., et al., Molecular cloning and sequence analysis of the cDNA for a human serine protease reponsible for activation of hepatocyte growth factor. Structural similarity of the protease precursor to blood coagulation factor XII. J. Biol. Chem. 1993, 268, 10024-10028.
41. Cai, W., Rook, S. L., Jiang, Z. Y., Takahara, N., Aiello, L. P., Mechanisms of hepatocyte growth factor-induced retinal endothelial cell migration and growth. Invest. Ophthalmol. Vis. Sci. 2000, 47, 1885-1893.
42. Clermont, A. C., Cahill, M., Salti, H., Rook, S. L., et al., Hepatocyte growth factor induces retinal vascular permeability via MAP-kinase and PI-3 kinase without altering retinal hemodynamics. Invest. Ophthalmol. Vis. Sci 2006, 47, 2701-2708.
43. Grant, D. S., Kleinman, H. K., Goldberg, I. D., Bhargava, M. M., et al., Scatter factor induces blood vessel formation in vivo. Proc. Natl. Acad. Sci. USA 1993, 90, 1937-1941.
44. Chiarelli, F., Pomilio, M., Mohn, A., Tumini, S., et al., Serum angiogenin concentrations in young patients with diabetes mellitus. Eur. J. Clin. Invest. 2002, 32, 110-114.
45. Fett, J. W., Strydom, D. J., Lobb, R. R., Alderman, E. M., et al., Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells. Biochemistry 1985, 24, 5480-5486.
46. Kase, S., Yokoi, M., Saito, W., Furudate, N., et al., Increased osteopontin levels in the vitreous of patients with diabetic retinopathy. Ophthalmic Res. 2007, 39, 143-147.
47. Danser, A. H., Derkx, F. H., Admiraal, P. J., Deinum, J., et al., Angiotensin levels in the eye. Invest. Ophthalmol. Vis. Sci. 1994, 35, 1008-1018.
48. Fernandez, L. A., Twickler, J., Mead, A., Neovascularization produced by angiotensin II. J. Lab. Clin. Med. 1985, 105, 141-145.
49. Sramek, S. J., Wallow, I. H., Tewksbury, D. A., Brandt, C. R., Poulsen, G. L., An ocular renin-angiotensin system. Immunohistochemistry of angiotensinogen. Invest. Ophthalmol. Vis. Sci. 1992, 33, 1627-1632.
50. Chaturvedi, N., Sjolie, A. K., Stephenson, J. M., Abrahamian, H., et al., Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. The EUCLID Study Group. EURODIAB Controlled Trial of Lisinopril in Insulin-Dependent Diabetes Mellitus. Lancet 1998, 351, 28-31.
51. Rosenberg, M. E., Silkensen, J., Clusterin: Physiologic and pathophysiologic considerations. Int. J. Biochem. Cell Biol. 1995, 27, 633-645.
52. Kim, Y. S., Kim, Y. H., Cheon, E. W., Park, J. M., et al., Retinal expression of clusterin in the streptozotocin-induced diabetic rat. Brain Res. 2003, 976, 53-59.
53. Jackson, J. K., Gleave, M. E., Gleave, J., Burt, H. M., The inhibition of angiogenesis by antisense oligonucleotides to clusterin. Angiogenesis 2005, 8, 229-238.
54. Gabay, C., Kushner, I., Acute-phase proteins and other systemic responses to inflammation. New Eng. J. Med. 1999, 340, 448-454.
55. Gerhardinger, C., Costa, M. B., Coulombe, M. C., Toth, I., et al., Expression of acute-phase response proteins in retinal Muller cells in diabetes. Invest. Ophthalmol. Vis. Sci. 2005, 46, 349-357.
56. Cappelli-Bigazzi, M., Ambrosio, G., Musci, G., Battaglia, C., et al., Ceruloplasmin impairs endothelium-dependent relaxation of rabbit aorta. Am. J. Physiol. 1997, 273, H2843-H2849.
57. Carlevaro, M. F., Albini, A., Ribatti, D., Gentili, C., et al., Transferrin promotes endothelial cell migration and invasion: Implication in cartilage neovascularization. J. Cell Biol. 1997, 136, 1375-1384.
58. Fujino, T., Asaba, H., Kang, M. J., Ikeda, Y., et al., Low-density lipoprotein receptor-related protein 5 (LRP5) is essential for normal cholesterol metabolism and glucose-induced insulin secretion. Proc. Natl. Acad. Sci. USA 2003, 100, 229-234.
59. Hunter, D. D., Zhang, M., Ferguson, J. W., Koch, M., Brunken, W. J., The extracellular matrix component WIF-1 is expressed during, and can modulate, retinal development. Mol. Cell. Neurosci. 2004, 27, 477-488.
60. Taniguchi, H., Yamamoto, H., Hirata, T., Miyamoto, N., et al., Frequent epigenetic inactivation of Wnt inhibitory factor-1 in human gastrointestinal cancers. Oncogene 2005, 24, 7946-7952.
61. Hackam, A. S., The Wnt signaling pathway in retinal degenerations. IUBMB Life 2005, 57, 381-388.